# Revolution Medicines, Inc. (RVMD): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rvmd for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective in...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $186.99 USD |
| Market Cap | $40.08B |
| P/E (TTM) | — |
| EPS (TTM) | −$8.82 |
| 52-Week Range | $55.40 – $224.31 |
| Dividend Yield (TTM) | — |

## Dividend

RVMD has no dividend payment history in our records.

## Frequently Asked Questions

### What does Revolution Medicines, Inc. do?

Revolution Medicines, Inc. (RVMD) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RVMD's market cap?

Revolution Medicines, Inc. (RVMD) has a market capitalization of approximately $40.08 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does RVMD pay a dividend?

No, Revolution Medicines, Inc. (RVMD) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is RVMD profitable?

Revolution Medicines, Inc. (RVMD) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has RVMD ever paid a dividend?

No. Dividend Data's records show no dividend payments from Revolution Medicines, Inc. (RVMD). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rvmd
- Dividend history & safety: https://www.dividenddata.com/stocks/rvmd/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rvmd/earnings
- Financial statements: https://www.dividenddata.com/stocks/rvmd/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rvmd/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rvmd/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.